{
    "NCTID": "NCT00543210",
    "trial_id": "gYvAzyT6w0P6E9eTwINS",
    "phase": "Phase III",
    "title": "Double-blind Study of 3,4-Diaminopyridine in Lambert-Eaton Myasthenic Syndrome",
    "brief_summary": "Evaluating the efficacy of 3,4-Diaminopyridine in improving neuromuscular transmission in LEMS patients.",
    "drug": "3,4-Diaminopyridine",
    "description": "This trial focuses on assessing the improvement in muscle strength and reduction in fatigue among patients with Lambert-Eaton Myasthenic Syndrome through administration of 3,4-Diaminopyridine.",
    "disease_targeted": "Lambert-Eaton Myasthenic Syndrome",
    "inclusion_criteria": [
      { "criterion": "Confirmed diagnosis of LEMS." },
      { "criterion": "Aged 18 and older." }
    ],
    "exclusion_criteria": [
      { "criterion": "History of cardiac arrhythmia." },
      { "criterion": "Recent use of immunosuppressive drugs." }
    ],
    "enrollment_capacity": 100,
    "sponsor": "Neuromuscular Research Group",
    "locations": [
      {
        "location_id": "LOC3004",
        "address": "101 Neurology Lane",
        "city": "New York",
        "state": "NY",
        "country": "USA"
      },
      {
        "location_id": "LOC3005",
        "address": "202 Science Park",
        "city": "Chicago",
        "state": "IL",
        "country": "USA"
      }
    ],
    "start_date": "2024-09-01T00:00:00Z",
    "end_date": "2026-09-01T00:00:00Z",
    "status": "completed",
    "contact_info": {
      "phone": "+1-212-555-0303",
      "email": "lemstrial@neuromusculargroup.org",
      "website": "https://www.neuromusculargroup.org/LEMS"
    },
    "data_security_details": "Patient information is encrypted in transit and at rest with access restricted to authorized personnel.",
    "study_results": [
      {
        "date": "2026-10-10T00:00:00Z",
        "result_summary": "Trial met primary endpoints with significant improvements in neuromuscular function.",
        "outcome": "positive"
      }
    ],
    "adverse_events": [
      {
        "date": "2025-11-15T00:00:00Z",
        "event_description": "Moderate headache and dizziness reported by several participants.",
        "severity": "moderate"
      },
      {
        "date": "2025-12-01T00:00:00Z",
        "event_description": "Severe allergic reaction in one patient, resolved after treatment.",
        "severity": "severe"
      }
    ],
    "created_at": "2024-08-20T08:00:00Z",
    "updated_at": "2026-10-11T09:30:00Z",
    "additional_comments": [
      "Study design included a double-blind placebo-controlled phase."
    ],
    "matching_criteria": [
      "neuromuscular function tests",
      "positive antibody test for VGCC"
    ]
  }
  